167 related articles for article (PubMed ID: 37196045)
1. Determinants of influenza and pneumococcal vaccine uptake among preschool children in Singapore.
Zahari M; Offeddu V; Smith GJD; Tam CC
PLoS One; 2023; 18(5):e0285561. PubMed ID: 37196045
[TBL] [Abstract][Full Text] [Related]
2. Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment.
How CH; Phua See Chun P; Shafi F; Jakes RW
BMC Public Health; 2016 Sep; 16(1):923. PubMed ID: 27590503
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
4. A community-based cross-sectional immunisation survey in parents of primary school students.
Hon KL; Tsang YC; Chan LC; Ng DK; Miu TY; Chan JY; Lee A; Leung TF;
NPJ Prim Care Respir Med; 2016 Apr; 26():16011. PubMed ID: 27053378
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
[No Abstract] [Full Text] [Related]
6. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status.
van Santen KL; Bednarczyk RA; Adjaye-Gbewonyo D; Orenstein WA; Davis R; Omer SB
Pediatr Infect Dis J; 2013 Nov; 32(11):1180-4. PubMed ID: 23856786
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2019 May; 5(5):CD001480. PubMed ID: 31135969
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines.
Wondimu A; Cao Q; Wilschut JC; Postma MJ
BMC Public Health; 2019 Dec; 19(1):1656. PubMed ID: 31823756
[TBL] [Abstract][Full Text] [Related]
10. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010.
Thoon KC; Chong CY; Tee NW
Int J Infect Dis; 2012 Mar; 16(3):e209-15. PubMed ID: 22281191
[TBL] [Abstract][Full Text] [Related]
11. Spatial variation and predictors of incomplete pneumococcal conjugate vaccine (PCV) uptake among children aged 12-35 months in Ethiopia: spatial and multilevel analyses.
Hailegebireal AH; Hailegebreal S; Tirore LL; Wolde BB
Front Public Health; 2024; 12():1344089. PubMed ID: 38864011
[TBL] [Abstract][Full Text] [Related]
12. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
[TBL] [Abstract][Full Text] [Related]
14. Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011.
Otieno NA; Nyawanda BO; Audi A; Emukule G; Lebo E; Bigogo G; Ochola R; Muthoka P; Widdowson MA; Shay DK; Burton DC; Breiman RF; Katz MA; Mott JA
Vaccine; 2014 Nov; 32(49):6699-704. PubMed ID: 24462406
[TBL] [Abstract][Full Text] [Related]
15. Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
Benedict Kpozehouen E; Macintyre CR; Tan TC
Vaccine; 2024 May; 42(15):3404-3409. PubMed ID: 38704255
[TBL] [Abstract][Full Text] [Related]
16. Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: a case-control study.
Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; María Mayoral J; Martín V; María Quintana J; González-Candelas F; Galán JC; Tamames S; Acosta AC; Baricot M; Garín O; José García J; Moraga F; Pumarola T;
Pediatr Infect Dis J; 2013 Apr; 32(4):330-4. PubMed ID: 23337901
[TBL] [Abstract][Full Text] [Related]
17. A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain.
Asensi F; De Jose M; Lorente M; Moraga F; Ciuryla V; Arikian S; Casciano R; Vento M
Value Health; 2004; 7(1):36-51. PubMed ID: 14720129
[TBL] [Abstract][Full Text] [Related]
18. Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.
McFarland M; Szasz TP; Zhou JY; Motley K; Sivapalan JS; Isaacson-Schmid M; Todd EM; Hogan PG; Fritz SA; Burnham CD; Hoffmann S; Morley SC
Vaccine; 2017 Aug; 35(34):4389-4395. PubMed ID: 28687405
[TBL] [Abstract][Full Text] [Related]
19. Physician perspectives regarding pneumococcal conjugate vaccine.
Schaffer SJ; Szilagyi PG; Shone LP; Ambrose SJ; Dunn MK; Barth RD; Edwards K; Weinberg GA; Balter S; Schwartz B
Pediatrics; 2002 Dec; 110(6):e68. PubMed ID: 12456935
[TBL] [Abstract][Full Text] [Related]
20. What is associated with reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS survey.
Gosling J; Colbourn T
PLoS One; 2023; 18(3):e0283760. PubMed ID: 37000716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
